136 related articles for article (PubMed ID: 10998135)
21. A case of paraneoplastic elastosis perforans serpiginosa associated with ovarian malignancy.
Quinlan C; Boggs J; Finan M; Mulligan N; Gulmann C; O'Kane M; Ralph N
Int J Dermatol; 2018 Apr; 57(4):470-472. PubMed ID: 29355938
[TBL] [Abstract][Full Text] [Related]
22. Elastosis perforans serpiginosa: clinical, histomorphological and immunological studies.
van Joost T; Vuzevski VD; ten Kate FJ; Stolz E; Heule F
J Cutan Pathol; 1988 Apr; 15(2):92-7. PubMed ID: 3372794
[TBL] [Abstract][Full Text] [Related]
23. D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease.
Amichai B; Rotem A; Metzker A
Isr J Med Sci; 1994 Aug; 30(8):667-9. PubMed ID: 8045756
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of 1,25-dihydroxyvitamin-D-induced keratinocyte differentiation by blocking the expression of phospholipase C-gamma1.
Xie Z; Bikle DD
J Invest Dermatol; 2001 Nov; 117(5):1250-4. PubMed ID: 11710940
[TBL] [Abstract][Full Text] [Related]
25. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine.
Bécuwe C; Dalle S; Ronger-Savlé S; Skowron F; Balme B; Kanitakis J; Thomas L
Dermatology; 2005; 210(1):60-3. PubMed ID: 15604549
[TBL] [Abstract][Full Text] [Related]
26. Expression of microfibril-associated glycoprotein-1 (MAGP-1) in human epidermal keratinocytes.
Fujimoto N; Tajima S; Ishibashi A
Arch Dermatol Res; 2000 Jan; 292(1):21-6. PubMed ID: 10664011
[TBL] [Abstract][Full Text] [Related]
27. Structural alterations of collagen fibrils in the reactive type of elastosis perforans serpiginosa.
Ludatscher RM; Friedman-Birnbaum R; Bergman R; Lichtig C
Arch Dermatol Res; 1988; 280(5):319-22. PubMed ID: 3178288
[No Abstract] [Full Text] [Related]
28. STAT5a/PPARgamma pathway regulates involucrin expression in keratinocyte differentiation.
Dai X; Sayama K; Shirakata Y; Hanakawa Y; Yamasaki K; Tokumaru S; Yang L; Wang X; Hirakawa S; Tohyama M; Yamauchi T; Takashi K; Kagechika H; Hashimoto K
J Invest Dermatol; 2007 Jul; 127(7):1728-35. PubMed ID: 17330131
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
30. Platelet-Released Growth Factors Induce Differentiation of Primary Keratinocytes.
Bayer A; Tohidnezhad M; Lammel J; Lippross S; Behrendt P; Klüter T; Pufe T; Jahr H; Cremer J; Rademacher F; Gläser R; Harder J
Mediators Inflamm; 2017; 2017():5671615. PubMed ID: 28808357
[TBL] [Abstract][Full Text] [Related]
31. An ultrastructural study of the reactive type of elastosis perforans serpiginosa.
Bergman R; Friedman-Birnbaum R; Ludatscher R; Lichtig C
Arch Dermatol; 1987 Sep; 123(9):1127-9. PubMed ID: 3631997
[No Abstract] [Full Text] [Related]
32. [Elastosis perforans serpiginosa. Considerations on the pathogenesis based on a typical case].
Kretzschmar L; Hamm H; John SM; Bröcker EB
Hautarzt; 1992 Oct; 43(10):640-4. PubMed ID: 1358859
[TBL] [Abstract][Full Text] [Related]
33. Imiquimod therapy for elastosis perforans serpiginosa.
Kelly SC; Purcell SM
Arch Dermatol; 2006 Jul; 142(7):829-30. PubMed ID: 16847197
[No Abstract] [Full Text] [Related]
34. Elastosis perforans serpiginosa.
Lee SH; Choi Y; Kim SC
Ann Dermatol; 2014 Feb; 26(1):103-6. PubMed ID: 24648695
[TBL] [Abstract][Full Text] [Related]
35. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro.
Akaza N; Akamatsu H; Kishi M; Mizutani H; Ishii I; Nakata S; Matsunaga K
J Dermatol; 2009 Apr; 36(4):213-23. PubMed ID: 19348660
[TBL] [Abstract][Full Text] [Related]
36. Suppression of cornified envelope formation and type 1 transglutaminase by epidermal growth factor in neoplastic keratinocytes.
Monzon RI; McWilliams N; Hudson LG
Endocrinology; 1996 May; 137(5):1727-34. PubMed ID: 8612508
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis.
Steude J; Kulke R; Christophers E
J Invest Dermatol; 2002 Dec; 119(6):1254-60. PubMed ID: 12485425
[TBL] [Abstract][Full Text] [Related]
38. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes.
Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S
J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295
[TBL] [Abstract][Full Text] [Related]
39. D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature.
Atzori L; Pinna AL; Pau M; Aste N
Dermatol Online J; 2011 Apr; 17(4):3. PubMed ID: 21549078
[TBL] [Abstract][Full Text] [Related]
40. Effects of a calcium receptor activator on the cellular response to calcium in human keratinocytes.
Tu CL; Oda Y; Bikle DD
J Invest Dermatol; 1999 Sep; 113(3):340-5. PubMed ID: 10469331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
